Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

81° Sunny
- Wapakoneta, OH (45895)
  Today
  
  Thunderstorms - some may contain locally heavy rain, especially this evening. Low 64F. Winds light and variable. Chance of rain 70%..
  
  Tonight
  
  Thunderstorms - some may contain locally heavy rain, especially this evening. Low 64F. Winds light and variable. Chance of rain 70%.
  
  Updated: September 17, 2026 @ 6:08 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Morgan Stanley (NY:MS)

206.12 +3.54 (+1.75%)

Official Closing Price Updated: 4:10 PM EDT, Sep 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Morgan Stanley

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand ↗

Today 16:02 EDT

ResMed (NYSE:RMD) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing...

Via MarketBeat

Why Marvell Stock Rallied Today ↗

Today 15:01 EDT

The chipmaker announced plans to unveil next-generation technology at an upcoming tech conference.

Via The Motley Fool

Topics Artificial Intelligence

Moderna (MRNA) Stock Trades Up, Here Is Why

Today 13:05 EDT

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.4% in the afternoon session after positive Phase 3 INTerpath-001 trial results ...

Via StockStory

Topics Artificial Intelligence

Tesla Opens Roadster Preorders; More SpaceX Merger Talks Surface ↗

Today 12:53 EDT

A combined Tesla and SpaceX would dominate physical AI applications, according to Morgan Stanley. Both stocks gained on Monday.

Via Investor's Business Daily

Topics Artificial Intelligence

Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig ↗

Today 5:02 EDT

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring of...

Via MarketBeat

Morgan Stanley Investment Management's 1GT Leads €49 Million Series E Funding for Amber Electric

Today 4:07 EDT

From Morgan Stanley Investment Management

Via Business Wire

Ardelyx Targets $500M Revenue This Year, Profitability by 2027 ↗

Today 4:02 EDT

Ardelyx (NASDAQ:ARDX) expects to generate close to $500 million in revenue this year and reach profitability in 2027, supported by continued growth of its IBS-C treatment IBSRELA and hyperphosphatemia...

Via MarketBeat

Cognex Touts AI Vision Growth Across Data Centers, Semis and China ↗

Today 2:02 EDT

Cognex (NASDAQ:CGNX) Chief Financial Officer Dennis Fehr said the machine-vision company is pursuing growth across logistics, packaging, semiconductors, electronics and data-center supply chains,...

Via MarketBeat

Topics Artificial Intelligence

1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm

Today 0:43 EDT

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference ↗

September 20, 2026

NeoGenomics (NASDAQ:NEO) executives outlined the company’s strategy to expand its role in community-based precision oncology, emphasizing growth in next-generation sequencing, minimal residual disease...

Via MarketBeat

Recursion Pharmaceuticals Highlights AI Drug Platform, FAP Progress at Morgan Stanley Conference ↗

September 20, 2026

Recursion Pharmaceuticals (NASDAQ:RXRX) outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley’s Global Healthcare Conference, with CEO and President Najat Khan emphasizing...

Via MarketBeat

Topics Artificial Intelligence

Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances ↗

September 20, 2026

Helus Pharma Chief Executive Officer Michael Halstead said the company expects a pivotal Phase III readout for its HLP003 program in adjunctive major depressive disorder in the fourth quarter,...

Via MarketBeat

Aurora Innovation Targets 20 Driverless Trucks a Week as DaaS Shift Takes Shape ↗

September 20, 2026

Aurora Innovation (NASDAQ:AUR) is preparing to expand its autonomous-trucking operations through a second-generation hardware rollout, a planned transition toward a driver-as-a-service model and...

Via MarketBeat

Topics Artificial Intelligence

Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B ↗

September 20, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) executives outlined the company’s oncology growth strategy, early commercial progress for recently launched therapies and business-development priorities during the...

Via MarketBeat

Topics Cannabis

WW International Eyes Cash Flow Turnaround as GLP-1 Care Gains Momentum ↗

September 20, 2026

WW International (NASDAQ:WW) executives outlined the company’s efforts to reposition its weight-management business around behavioral support, telehealth and GLP-1 medications, following a...

Via MarketBeat

Topics Supply Chain

Stanley Black & Decker Targets Margin Gains as DEWALT Takes Share ↗

September 20, 2026

Stanley Black & Decker (NYSE:SWK) CEO Chris Nelson said the company is progressing against three priorities: strengthening its core brands, improving operational execution and accelerating innovation....

Via MarketBeat

Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗

September 20, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) highlighted continued momentum for its AMVUTTRA treatment in transthyretin-mediated cardiomyopathy, while outlining a pipeline of upcoming clinical catalysts and...

Via MarketBeat

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets ↗

September 20, 2026

IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare...

Via MarketBeat

Topics ETFs

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference ↗

September 20, 2026

IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product...

Via MarketBeat

Topics ETFs

Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss ↗

September 20, 2026

Sanofi (NASDAQ:SNY) is prioritizing continued growth in Specialty Care while preparing for the loss of exclusivity of Dupixent in the early part of the next decade, according to Manuela Buxo, the...

Via MarketBeat

Topics Intellectual Property

Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push ↗

September 20, 2026

Pacific Biosciences of California (NASDAQ:PACB) is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve...

Via MarketBeat

Rockwell Automation Sees Data Centers, Labor Crunch Fueling Automation Demand ↗

September 19, 2026

Rockwell Automation (NYSE:ROK) executives said customer sentiment remains broadly positive despite inflation, tariffs and trade-policy uncertainty, with manufacturers continuing to prioritize...

Via MarketBeat

Topics Economy World Trade

Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds ↗

September 19, 2026

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what...

Via MarketBeat

Topics World Trade

Boeing Isn't Perfect -- but It's Still a Compelling Value Buy Right Now ↗

September 19, 2026

Boeing's slow progress is not being recognized yet by the market.

Via The Motley Fool

Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction ↗

September 19, 2026

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is seeing accelerating prescription growth for AUVELITY following its sales-force expansion and the recent launch of the drug in...

Via MarketBeat

26 Analysts Covering SpaceX Stock Rate It a Buy. Here's Why 8 Analysts Disagree ↗

September 19, 2026

Wall Street remains very bullish on SpaceX stock.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

United Rentals Sees Large-Project Pipeline Accelerate as Specialty Demand Stays Strong ↗

September 19, 2026

United Rentals (NYSE:URI) executives said construction-equipment rental demand has exceeded the company’s expectations this year, led by an accelerating pipeline of large projects and supported by...

Via MarketBeat

Topics Bonds Economy Energy

Ionis Pharmaceuticals Eyes TRYNGOLZA Growth as Pipeline Faces Cardio Setbacks ↗

September 19, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia outlined recent regulatory wins, commercial-launch progress and several pipeline updates at the Morgan Stanley Global Healthcare Conference, while...

Via MarketBeat

Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances ↗

September 19, 2026

Intellia Therapeutics (NASDAQ:NTLA) executives outlined plans for a potential launch of its hereditary angioedema treatment, lonvo-z, while discussing the company’s ongoing Phase III program in...

Via MarketBeat

Topics Intellectual Property

BioCryst Eyes $1B Rare-Disease Future Through External Innovation ↗

September 18, 2026

BioCryst Pharmaceuticals (NASDAQ:BCRX) is shifting its strategy toward external innovation as it seeks to expand beyond its ORLADEYO hereditary angioedema, or HAE, franchise, newly appointed Chief...

Via MarketBeat

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Business
Local Events
Entertainment
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Wapakoneta Daily News

wapakdailynews.com
520 Industrial Drive
Wapakoneta, OH 45895
Phone: 419-738-2128
Email: marketing@wapakwdn.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Wapakoneta, OH (45895)

Today

Tonight

Morgan Stanley (NY:MS)

All News about Morgan Stanley

Sections

Services

Wapakoneta Daily News